The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil (Q34118020)

31 July 2017

title

The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil (English)

1 reference

31 July 2017

Saenz de Tejada I

1

1 reference

31 July 2017

Angulo J

2

1 reference

31 July 2017

Cuevas P

3

1 reference

31 July 2017

Fernández A

4

1 reference

31 July 2017

Moncada I

5

1 reference

31 July 2017

Allona A

6

1 reference

31 July 2017

Lledó E

7

1 reference

31 July 2017

Körschen HG

8

1 reference

31 July 2017

Niewöhner U

9

1 reference

31 July 2017

Haning H

10

1 reference

31 July 2017

Pages E

11

1 reference

31 July 2017

Bischoff E

12

1 reference

31 July 2017

publication date

1 October 2001

1 reference

International Journal of Impotence Research

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

282-290

1 reference

About arterial risk factors and impotence

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

1 reference

7 January 2021

Erectile dysfunction due to atherosclerotic vascular disease: the development of an animal model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Nitric oxide: a physiologic mediator of penile erection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Role of nitric oxide in the physiology of erection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Expression of different phosphodiesterase genes in human cavernous smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Nitric oxide is involved in the inhibitory neurotransmission and endothelium-dependent relaxations of human small penile arteries.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Neuroleptics induce penile erection in the rabbit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

The role of phosphodiesterase inhibitors in impotence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Hypercholesterolemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: a multi-institutional study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Vardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3900726

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3900726

1 reference

Dimensions Publication ID

31 July 2017

1037765808

0 references

1 reference